{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:22:52Z","timestamp":1787966572115,"version":"build-2784847793"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/dmd.124.001916","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:55:19Z","timestamp":1730814919000},"page":"100023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation"],"prefix":"10.1016","volume":"53","author":[{"given":"Zhuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"McCalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Tornichio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw","family":"Agyemang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Bastulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun Susan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001916_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A\u00a0placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1124\/dmd.124.001916_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2710.2005.00646.x","article-title":"Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays","volume":"30","author":"Arafat","year":"2005","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1124\/dmd.124.001916_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpba.2005.11.020","article-title":"Validated HPLC\u2013MS\/MS method for simultaneous determination of simvastatin and\u00a0simvastatin hydroxy acid in human plasma","volume":"41","author":"Barrett","year":"2006","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1124\/dmd.124.001916_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","article-title":"Clopidogrel\u2013drug interactions","volume":"57","author":"Bates","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1124\/dmd.124.001916_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(95)91209-6","article-title":"Prolonged sedation due to accumulation of conjugated metabolites of midazolam","volume":"346","author":"Bauer","year":"1995","journal-title":"Lancet"},{"key":"10.1124\/dmd.124.001916_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/acem.12875","article-title":"Incidence of adverse events in adults undergoing procedural sedation in the emergency department: a systematic review and meta-analysis","volume":"23","author":"Bellolio","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1124\/dmd.124.001916_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","article-title":"Statin drug interactions and related adverse reactions: an update","volume":"17","author":"Bellosta","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/dmd.124.001916_bib8","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1213\/ANE.0000000000002022","article-title":"Inhaled remimazolam potentiates inhaled remifentanil in rodents","volume":"124","author":"Bevans","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1124\/dmd.124.001916_bib9","article-title":"Associations between CES1 variants and dosing and adverse effects in children taking methylphenidate","volume":"10","author":"Brown","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1124\/dmd.124.001916_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12793\/tcp.2014.22.1.30","article-title":"Genetic polymorphisms of the carboxylesterase 1 (CES1) gene in a Korean population","volume":"22","author":"Cha","year":"2014","journal-title":"Transl Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijms.2023.117120","article-title":"Development and validation of an HPLC-MS\/MS assay for the quantitative analysis of remimazolam in critically ill patients","volume":"492","author":"Chen","year":"2023","journal-title":"Int J Mass Spectrom"},{"key":"10.1124\/dmd.124.001916_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","article-title":"Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote","volume":"42","author":"Chen","year":"2020","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.124.001916_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gie.2024.04.001","article-title":"Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study","volume":"100","author":"Choe","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1124\/dmd.124.001916_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/fcp.12021","article-title":"Investigation of drug\u2013drug interactions between clopidogrel and fluoxetine","volume":"27","author":"Delavenne","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib15","article-title":"The rise of remimazolam: a review of pharmacology, clinical efficacy, and safety profiles","volume":"16","author":"Dessai","year":"2024","journal-title":"Cureus"},{"key":"10.1124\/dmd.124.001916_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.118.083832","article-title":"Mechanistic in\u00a0vitro studies indicate that the clinical drug-drug interaction between telithromycin and simvastatin acid is driven by time-dependent inhibition of CYP3A4 with minimal effect on OATP1B1","volume":"47","author":"Elsby","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001916_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/clpt.2012.163","article-title":"Understanding the critical disposition pathways of statins to assess drug\u2013drug interaction risk during drug development: it\u2019s not just about OATP1B1","volume":"92","author":"Elsby","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001916_bib18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S186759","article-title":"Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system","volume":"13","author":"Freyer","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/dmd.124.001916_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/1658-354X.136627","article-title":"Remimazolam: the future of its sedative potential","volume":"8","author":"Goudra","year":"2014","journal-title":"Saudi J Anaesth"},{"key":"10.1124\/dmd.124.001916_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/cp.1999.v66.100038001","article-title":"Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in\u00a0vivo and in\u00a0vitro study","volume":"66","author":"Hamaoka","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001916_bib21","series-title":"Pediatric Critical Care","first-page":"1654","article-title":"Sedation and analgesia","author":"Heard","year":"2011"},{"key":"10.1124\/dmd.124.001916_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/dmd.119.089680","article-title":"Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators","volume":"48","author":"Her","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001916_bib23","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1111\/bcp.14888","article-title":"Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects","volume":"87","author":"Her","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuro.2009.04.003","article-title":"Interaction between human serum esterases and environmental metal compounds","volume":"30","author":"Hern\u00e1ndez","year":"2009","journal-title":"NeuroToxicology"},{"key":"10.1124\/dmd.124.001916_bib25","first-page":"1746","article-title":"CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease","volume":"124","author":"Hoh","year":"2016","journal-title":"J\u00a0Neurosurg"},{"key":"10.1124\/dmd.124.001916_bib26","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.2147\/DDDT.S384155","article-title":"Remimazolam: an updated review of a new sedative and anaesthetic","volume":"16","author":"Hu","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/dmd.124.001916_bib27","first-page":"580","article-title":"The influence of the CES1 genotype on the pharmacokinetics of enalapril in patients with arterial hypertension","volume":"12","author":"Ikonnikova","year":"2022","journal-title":"J\u00a0Pers Med"},{"key":"10.1124\/dmd.124.001916_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.124.001916_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/cap.2013.0032","article-title":"Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit\/hyperactivity disorder-associated CES1 gene","volume":"23","author":"Johnson","year":"2013","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1124\/dmd.124.001916_bib30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.124.001916_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40265-020-01299-8","article-title":"Remimazolam: first approval","volume":"80","author":"Keam","year":"2020","journal-title":"Drugs"},{"key":"10.1124\/dmd.124.001916_bib32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/EJA.0000000000001902","article-title":"Remimazolam and serious adverse events: a scoping review","volume":"40","author":"Kempenaers","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"10.1124\/dmd.124.001916_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting benzodiazepine","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.124.001916_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17085\/apm.21115","article-title":"Remimazolam: pharmacological characteristics and clinical applications in anesthesiology","volume":"17","author":"Kim","year":"2022","journal-title":"Anesth Pain Med (Seoul)"},{"key":"10.1124\/dmd.124.001916_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1755-5922.12183","article-title":"Pharmacodynamic and pharmacokinetic profiles of sacubitril\/valsartan (LCZ696) in patients with heart failure and reduced ejection fraction","volume":"34","author":"Kobalava","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1124\/dmd.124.001916_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173639","article-title":"Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys","volume":"890","author":"Kops","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.124.001916_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00498254.2019.1612535","article-title":"Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition","volume":"50","author":"Laizure","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.124.001916_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.113.054353","article-title":"Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis","volume":"42","author":"Laizure","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001916_bib41","first-page":"457","article-title":"Remimazolam: another option for induction of general anesthesia?","volume":"75","author":"Lee","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"10.1124\/dmd.124.001916_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e32835aa8a2","article-title":"The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response","volume":"23","author":"Lewis","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.124.001916_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/pharmaceutics16020234","article-title":"Simultaneously predicting the pharmacokinetics of ces1-metabolized drugs and their metabolites using physiologically based pharmacokinetic model in cirrhosis subjects","volume":"16","author":"Luo","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1124\/dmd.124.001916_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cts.12423","article-title":"Population pharmacokinetics of methylphenidate in healthy adults emphasizing novel and known effects of several carboxylesterase 1 (CES1) variants","volume":"9","author":"Lyauk","year":"2016","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.124.001916_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2165\/00003088-199325040-00003","article-title":"Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overview","volume":"25","author":"MacFadyen","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.124.001916_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/14740338.2012.631910","article-title":"Epidemiology and characteristics of adverse drug reactions caused by drug\u2013drug interactions","volume":"11","author":"Magro","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/dmd.124.001916_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/NAQ.0000000000000204","article-title":"Certified registered nurse anesthetist perceptions of factors impacting patient safety","volume":"41","author":"McMullan","year":"2017","journal-title":"Nurs Adm Q"},{"key":"10.1124\/dmd.124.001916_bib48","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neuropharm.2009.08.014","article-title":"Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD","volume":"57","author":"Nemoda","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.124.001916_bib49","doi-asserted-by":"crossref","DOI":"10.52965\/001c.24514","article-title":"A\u00a0comprehensive review of remimazolam for sedation","volume":"9","author":"Noor","year":"2021","journal-title":"Health Psychol Res"},{"key":"10.1124\/dmd.124.001916_bib50","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1345\/aph.1M051","article-title":"Drug\u2013drug interaction between clopidogrel and the proton pump inhibitors","volume":"43","author":"Norgard","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.124.001916_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/dmpt-2015-0034","article-title":"Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches","volume":"31","author":"Nzabonimpa","year":"2016","journal-title":"Drug Metab Pers Ther"},{"key":"10.1124\/dmd.124.001916_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176320","article-title":"The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans","volume":"12","author":"Oh","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/dmd.124.001916_bib53","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1186\/s12903-023-03538-2","article-title":"Efficacy and safety of remimazolam besilate for sedation in outpatients undergoing impacted third molar extraction: a prospective exploratory study","volume":"23","author":"Oue","year":"2023","journal-title":"BMC Oral Health"},{"key":"10.1124\/dmd.124.001916_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tgie.2016.02.004","article-title":"New horizons for sedation: the ultrashort acting benzodiazepine remimazolam","volume":"18","author":"Pambianco","year":"2016","journal-title":"Tech Gastrointest Endosc"},{"key":"10.1124\/dmd.124.001916_bib55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.clpt.6100082","article-title":"Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics","volume":"81","author":"Patrick","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001916_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bcpt.12434","article-title":"Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication--a systematic review with meta-analyses of randomised trials","volume":"118","author":"Penninga","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.124.001916_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40268-020-00317-0","article-title":"Remimazolam has low oral bioavailability and no potential for misuse in drug-facilitated sexual assaults, with or without alcohol: results from two randomised clinical trials","volume":"20","author":"Pesic","year":"2020","journal-title":"Drugs R D"},{"key":"10.1124\/dmd.124.001916_bib58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/0113892002300657240521094732","article-title":"Drug\u2013drug interaction potential of remimazolam: CYP 450, transporters, and protein binding","volume":"25","author":"Petersen","year":"2024","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.124.001916_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40140-023-00570-4","article-title":"Remimazolam in pediatric anesthesia and sedation","volume":"13","author":"Ramamurthi","year":"2023","journal-title":"Curr Anesthesiol Rep"},{"key":"10.1124\/dmd.124.001916_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200528030-00007","article-title":"Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy","volume":"28","author":"R\u00e4tz Bravo","year":"2005","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.124.001916_bib61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/0113892002301026240318060307","article-title":"The metabolism of the new benzodiazepine remimazolam","volume":"25","author":"Schmalix","year":"2024","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.124.001916_bib62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics","volume":"132","author":"Sch\u00fcttler","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.124.001916_bib63","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.115.068536","article-title":"Sacubitril is selectively activated by carboxylesterase 1 (CES1) in the liver and the activation is affected by CES1 genetic variation","volume":"44","author":"Shi","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001916_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bcp.2016.09.003","article-title":"Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender","volume":"119","author":"Shi","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2006.01.005","article-title":"Statin-related adverse events: a meta-analysis","volume":"28","author":"Silva","year":"2006","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.124.001916_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1213\/ANE.0b013e31823acb95","article-title":"Remimazolam: new beginnings or just a me-too?","volume":"115","author":"Sneyd","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1124\/dmd.124.001916_bib67","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ACO.0000000000000877","article-title":"Remimazolam for anaesthesia or sedation","volume":"33","author":"Sneyd","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1124\/dmd.124.001916_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bcpt.13212","article-title":"The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid\/methylphenidate ratios","volume":"125","author":"Stage","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.124.001916_bib69","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/bcp.13237","article-title":"The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects","volume":"83","author":"Stage","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bcpt.12835","article-title":"The pharmacokinetics of enalapril in relation to CES1 genotype in healthy Danish volunteers","volume":"121","author":"Stage","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.124.001916_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00228-012-1315-5","article-title":"The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans","volume":"69","author":"Suzaki","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib72","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","article-title":"Carboxylesterase in the liver and small intestine of experimental animals and human","volume":"81","author":"Taketani","year":"2007","journal-title":"Life Sci"},{"key":"10.1124\/dmd.124.001916_bib73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/clpt.2012.13","article-title":"Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans","volume":"92","author":"Tarkiainen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001916_bib74","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cpt.101","article-title":"Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans","volume":"97","author":"Tarkiainen","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001916_bib75","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/bcp.12667","article-title":"Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril","volume":"80","author":"Tarkiainen","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib76","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036081","article-title":"Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: a randomized controlled trial","volume":"102","author":"Toyota","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1124\/dmd.124.001916_bib77","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/bja\/73.5.658","article-title":"Midazolam is metabolized by at least three different cytochrome P450 enzymes","volume":"73","author":"Wandel","year":"1994","journal-title":"Br J Anaesth"},{"key":"10.1124\/dmd.124.001916_bib78","article-title":"A\u00a0comprehensive functional assessment of CES1 nonsynonymous variants","volume":"31","author":"Wang","year":"2017","journal-title":"FASEB J"},{"key":"10.1124\/dmd.124.001916_bib79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/tpj.2015.42","article-title":"CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors","volume":"16","author":"Wang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.124.001916_bib80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1248\/bpb.b14-00679","article-title":"Carboxylesterase 1-mediated drug-drug\u00a0interactions between clopidogrel and simvastatin","volume":"38","author":"Wang","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.124.001916_bib81","first-page":"449","article-title":"Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy","volume":"11","author":"Wang","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1124\/dmd.124.001916_bib82","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/phar.1806","article-title":"Remimazolam: pharmacologic considerations and clinical role in anesthesiology","volume":"36","author":"Wesolowski","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.124.001916_bib83","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpt.2111","article-title":"Physiologically based precision dosing approach for drug-drug-gene interactions: a simvastatin network analysis","volume":"109","author":"Wojtyniak","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001916_bib84","first-page":"7316","article-title":"Comparison of remimazolam-flumazenil versus propofol for recovery from general anesthesia: a systematic review and meta-analysis","volume":"12","author":"Wu","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1124\/dmd.124.001916_bib85","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1038\/s41598-017-07736-1","article-title":"Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients","volume":"7","author":"Xiao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.124.001916_bib86","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jsb.2006.08.015","article-title":"Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin","volume":"157","author":"Yang","year":"2007","journal-title":"J\u00a0Struct Biol"},{"key":"10.1124\/dmd.124.001916_bib87","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127009903901102","article-title":"Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam","volume":"39","author":"Yuan","year":"1999","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib88","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1097\/JS9.0000000000000638","article-title":"The safety and efficacy between remimazolam and propofol in intravenous anesthesia of endoscopy operation: a systematic review and meta-analysis","volume":"109","author":"Zhao","year":"2023","journal-title":"Int J Surg"},{"key":"10.1124\/dmd.124.001916_bib89","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/cts.13023","article-title":"A\u00a0population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedation","volume":"14","author":"Zhou","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.124.001916_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2020.109899","article-title":"Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects","volume":"66","author":"Zhou","year":"2020","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1124\/dmd.124.001916_bib91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpba.2017.01.016","article-title":"Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry","volume":"137","author":"Zhou","year":"2017","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1124\/dmd.124.001916_bib92","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00228-012-1350-2","article-title":"Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation","volume":"69","author":"Zhu","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001916_bib93","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","article-title":"Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis","volume":"82","author":"Zhu","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1124\/dmd.124.001916_bib94","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","article-title":"Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation","volume":"344","author":"Zhu","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:35:29Z","timestamp":1761194129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624148738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0090955624148738"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001916","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100023"}}